Trial intelligence / Profile preview

Dexmedetomidine as an Adjuvant to Bupivacaine in Bilateral PECs Block for Postoperative Pain After Cardiac Surgeries

NCT06453681Phase 4Completed

Sponsor
Kasr Al Ainy Hospital
Start
Aug 2024
Primary completion
Apr 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of dexmedetomidine in postoperative pain, sponsored by Kasr Al Ainy Hospital. Started Aug 2024; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT06453681.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06453681.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call